These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 7480892)

  • 21. Uptake and specific binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the olfactory mucosa of mice and rats.
    Gillner M; Brittebo EB; Brandt I; Söderkvist P; Appelgren LE; Gustafsson JA
    Cancer Res; 1987 Aug; 47(15):4150-9. PubMed ID: 3038308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
    Kupfer D; Mani C; Lee CA; Rifkind AB
    Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation-dependent induction of CYP1A1 in cultured rat small intestinal epithelial cells, colonocytes, and human colon carcinoma cells: basement membrane-mediated apoptosis.
    Sterling KM; Cutroneo KR
    J Cell Biochem; 2002; 86(3):440-50. PubMed ID: 12210751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mechanistic model of effects of dioxin on gene expression in the rat liver.
    Kohn MC; Lucier GW; Clark GC; Sewall C; Tritscher AM; Portier CJ
    Toxicol Appl Pharmacol; 1993 May; 120(1):138-54. PubMed ID: 8511776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promotion of endometriosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice: time-dose dependence and species comparison.
    Cummings AM; Metcalf JL; Birnbaum L
    Toxicol Appl Pharmacol; 1996 May; 138(1):131-9. PubMed ID: 8658502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Bhattacharya S; Conolly RB; Kaminski NE; Thomas RS; Andersen ME; Zhang Q
    Toxicol Sci; 2010 May; 115(1):51-65. PubMed ID: 20123757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complexities in understanding the nature of the dose-response for dioxins and related compounds.
    Walker NJ; Yang JH
    Dose Response; 2006 May; 3(3):267-72. PubMed ID: 18648623
    [No Abstract]   [Full Text] [Related]  

  • 29. Children's health, susceptibility, and regulatory approaches to reducing risks from chemical carcinogens.
    Charnley G; Putzrath RM
    Environ Health Perspect; 2001 Feb; 109(2):187-92. PubMed ID: 11266331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic modeling of rodent liver tumor promotion at low levels of exposure: an example related to dose-response relationships for 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Andersen ME; Conolly RB
    Hum Exp Toxicol; 1998 Dec; 17(12):683-90; discussion 701-4, 708-18. PubMed ID: 9988373
    [No Abstract]   [Full Text] [Related]  

  • 31. The toxicokinetics of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in mammalian systems.
    Neal RA; Olson JR; Gasiewicz TA; Geiger LE
    Drug Metab Rev; 1982; 13(3):355-85. PubMed ID: 7049640
    [No Abstract]   [Full Text] [Related]  

  • 32. Alternative models for low dose-response analysis of biochemical and immunological endpoints for tetrachlorodibenzo-p-dioxin.
    McGrath LF; Cooper KR; Georgopoulos P; Gallo MA
    Regul Toxicol Pharmacol; 1995 Jun; 21(3):382-96. PubMed ID: 7480892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2,3,7,8,-Tetrachlorodibenzo-p-dioxin: segregation of toxocity with the Ah locus.
    Poland A; Glover E
    Mol Pharmacol; 1980 Jan; 17(1):86-94. PubMed ID: 7383021
    [No Abstract]   [Full Text] [Related]  

  • 34. Application of a biologically-based RFD estimation method to tetrachlorodibenzo-p-dioxin (TCDD) mediated immune suppression and enzyme induction.
    McGrath LF; Georgopoulos P; Gallo MA
    Risk Anal; 1996 Aug; 16(4):539-48. PubMed ID: 8819344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction.
    Vanden Heuvel JP; Clark GC; Kohn MC; Tritscher AM; Greenlee WF; Lucier GW; Bell DA
    Cancer Res; 1994 Jan; 54(1):62-8. PubMed ID: 8261464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between CYP1A enzyme activities and protein levels in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    DeVito MJ; Beebe LE; Menache M; Birnbaum LS
    J Toxicol Environ Health; 1996 Mar; 47(4):379-94. PubMed ID: 8600290
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.